20LBA A double-blind, randomized study of denosumab versus zoledronic acid for the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma

D. Henry, Roger von Moos, Saroj Vadhan‐Raj, Vânia Hungria, Anne Spencer, Vera Hirsh, J. Wang, Seong Sook Jun, Hong‐Zen Yeh, Roger Dansey

European Journal of Cancer Supplements · 2009 · 72 citations · 0 references

Concepts